Days
Hours
Minutes
Seconds
-40%
on all subscriptions*
Exceptional extension!
Enjoy this offer
* See conditions under "Our services"

Valuation: AtriCure, Inc.

Market Cap 1.44B 1.27B 1.17B 1.09B 2.04B 136B 2.08B 14B 5.42B 66.94B 5.41B 5.29B 233B P/E 2026 *
620x
P/E 2027 * 83.7x
Enterprise Value 1.28B 1.13B 1.04B 973M 1.82B 122B 1.85B 12.48B 4.83B 59.69B 4.82B 4.72B 207B EV / Sales 2026 *
2.12x
EV / Sales 2027 * 1.78x
Free-Float
96.14%
Yield 2026 *
-
Yield 2027 * -
1 week+1.64%
Current month+2.78%
1 month-1.28%
3 months-4.50%
6 months-29.85%
Current year-28.11%
1 week 26.81
Extreme 26.81
29.03
1 month 25.36
Extreme 25.36
29.27
Current year 25.36
Extreme 25.36
43.18
1 year 25.36
Extreme 25.36
43.18
3 years 18.94
Extreme 18.94
59.61
5 years 18.94
Extreme 18.94
89.18
10 years 13.45
Extreme 13.45
89.18
Manager TitleAgeSince
Chief Executive Officer 55 2012-11-01
Director of Finance/CFO 48 2014-06-30
Chief Tech/Sci/R&D Officer 59 2017-07-17
Director TitleAgeSince
Director/Board Member 55 2012-11-01
Director/Board Member 64 2013-03-10
Director/Board Member 75 2016-11-09
Date Insider Type Main position Quantity % Market Cap.
May. 19Sell

Director

-3,000 0.0059%
May. 17Free

Director

6,144 0.0121%
May. 17Free

Director

6,144 0.0121%
Change 5-day change 1-year change 3-year change Capi.($)
0.00%+1.64%-10.85%-40.59% 1.44B
+3.07%-0.10%-32.07%-16.21% 153B
+1.72%-0.85%-6.20%-7.83% 101B
-1.82%-0.54%+56.86%+55.61% 55.9B
+3.62%-0.13%-4.10%+49.78% 52.78B
+2.28%-0.85%-15.20%-43.90% 38.77B
+1.70%-4.83% - - 29.35B
-0.22%-5.80%-13.68%-45.63% 26.65B
+2.03%+2.07%+55.23%-8.34% 23.29B
-2.25%-1.92%-16.37%-5.76% 20.51B
Average +1.00%-1.99%+1.51%-6.98% 50.32B
Weighted average by Cap. +1.71%-1.77%-5.47%-1.75%

Financials

2026 *2027 *
Net sales 605M 531M 490M 458M 859M 57.31B 873M 5.88B 2.28B 28.12B 2.27B 2.22B 97.73B 678M 596M 549M 514M 963M 64.27B 980M 6.59B 2.55B 31.53B 2.55B 2.49B 110B
Net income 2.66M 2.34M 2.15M 2.02M 3.78M 252M 3.84M 25.85M 10.01M 124M 9.99M 9.77M 430M 17.48M 15.36M 14.15M 13.25M 24.82M 1.66B 25.24M 170M 65.78M 813M 65.63M 64.22M 2.82B
Net Debt -156M -137M -126M -118M -221M -14.78B -225M -1.52B -587M -7.25B -586M -573M -25.2B -232M -204M -188M -176M -330M -22B -335M -2.26B -874M -10.8B -872M -853M -37.52B
Logo AtriCure, Inc.
AtriCure, Inc. provides technologies for the treatment for atrial fibrillation (Afib), left atrial appendage (LAA) management and post-operative pain management. The Company's cardiac ablation and left atrial appendage management (LAAM) products are used by physicians during open-heart and minimally invasive surgical procedures. Its pain management solutions are used by physicians to freeze nerves during cardiothoracic or thoracic surgical procedures. The Company's products for open and minimally invasive ablation include Isolator Synergy Clamps and Multifunctional Pens and Linear Ablation Devices. Its products for open ablation include cryoICE Cryoablation System. Its products for minimally invasive ablation include EPi-Sense Guided Coagulation System with VisiTrax Technology. Its appendage management products include AtriClip System. The Isolator Synergy Ablation System clamps are single-use disposable radio frequency (RF) products with jaws that close in a parallel fashion.
Employees
1,350
Date Price Change Volume
26-06-23 $28.44 0.00% 727,353
26-06-22 $28.44 -1.25% 696,566
26-06-18 $28.80 +6.19% 1,731,572
26-06-17 $27.12 -3.07% 828,896
26-06-16 $27.98 0.00% 702,635
Trader
Investor
Global
Quality
ESG MSCI
A
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
9
Last Close Price
28.44USD
Average target price
47.00USD
Spread / Average Target
+65.26%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. ATRC Stock
-40%: Exceptional extension
d
:
:
SEIZE THE OFFER!